CTKB Stock-Based Compensation
Cytek Biosciences Inc · Stock-Based Compensation
CTKB Stock-Based Compensation
Latest reported$21.37Mperiod ending
CTKB Stock-Based Comp ($269.00K → $21.37M)
Annual stock-based compensation
High-resolution chart · PNG
CTKB stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 24,585,000 | |
| 26,848,000 | |
| 22,048,000 | |
| 16,595,000 | |
| 6,586,000 | |
| 611,000 | |
| 269,000 |